Uncertainty Modeling in Dose Response

Inhaltsverzeichnis

Acknowledgments.

Contributors.

Introduction (Roger M. Cooke and Margaret MacDonell).

1 Analysis of Dose-Response Uncertainty Using Benchmark Dose Modeling (Jeff Swartout).

Comment: The Math/Stats Perspective on Chapter 1: Hard Problems Remain (Allan H. Marcus).

Comment: EPI/TOX Perspective on Chapter 1: Re-formulating the Issues (Jouni T. Tuomisto).

Comment: Regulatory/Risk Perspective on Chapter 1: A Good Baseline (Weihsueh Chiu).

Comment: A Question Dangles (David Bussard).

Comment: Statistical Test for Statistics-as-Usual Confidence Bands (Roger M. Cooke).

Response to Comments (Jeff Swartout).

2 Uncertainty Quantification for Dose-Response Models Using Probabilistic Inversion with Isotonic Regression: Bench Test Results (Roger M. Cooke).

Comment: Math/Stats Perspective on Chapter 2: Agreement and Disagreement (Thomas A. Louis).

Comment: EPI/TOX Perspective on Chapter 2: What Data Sets Per se Say (Lorenz Rhomberg).

Comment: Regulatory/Risk Perspective on Chapter 2: Substantial Advances Nourish Hope for Clarity? (Rob Goble).

Comment: A Weakness in the Approach? (Jouni T. Tuomisto).

Response to Comments (Roger Cooke).

3 Uncertainty Modeling in Dose Response Using Nonparametric Bayes: Bench Test Results (Lidia Burzala and Thomas A. Mazzuchi).

Comment: Math/Stats Perspective on Chapter 3: Nonparametric Bayes (Roger M. Cooke).

Comment: EPI/TOX View on Nonparametric Bayes: Dosing Precision (Chao W. Chen).

Comment: Regulator/Risk Perspective on Chapter 3: Failure to Communicate (Dale Hattis).

Response to Comments (Lidia Burzala).

4 Quantifying Dose-Response Uncertainty Using Bayesian Model Averaging (Melissa Whitney and Louise Ryan).

Comment: Math/Stats Perspective on Chapter 4: Bayesian Model Averaging (Michael Messner).

Comment: EPI/TOX Perspective on Chapter 4: Use of Bayesian Model Averaging for Addressing Uncertainties in Cancer Dose-Response Modeling (Margaret Chu).

Comment: Regulatorary/Risk Perspective on Chapter 4: Model Averages, Model Amalgams, and Model Choice (Adam M. Finkel).

Response to Comments (Melissa Whitney and Louise Ryan).

5 Combining Risks from Several Tumors Using Markov Chain Monte Carlo (Leonid Kopylev, John Fox, and Chao Chen).

6 Uncertainty in Dose Response from the Perspective of Microbial Risk (P. F. M. Teunis).

7 Conclusions (David Bussard, Peter Preuss, and Paul White).

Author Index.

Subject Index.

Uncertainty Modeling in Dose Response

Bench Testing Environmental Toxicity

Buch (Gebundene Ausgabe, Englisch)

176,99 €

inkl. gesetzl. MwSt.

Uncertainty Modeling in Dose Response

Ebenfalls verfügbar als:

Gebundenes Buch

Gebundenes Buch

ab 176,99 €
eBook

eBook

ab 123,99 €

Beschreibung

Details

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.07.2009

Verlag

John Wiley & Sons Inc

Seitenzahl

230

Maße (L/B/H)

23,7/16,3/1,9 cm

Beschreibung

Details

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.07.2009

Verlag

John Wiley & Sons Inc

Seitenzahl

230

Maße (L/B/H)

23,7/16,3/1,9 cm

Gewicht

481 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-470-44750-5

Weitere Bände von Statistics in Practice

Unsere Kundinnen und Kunden meinen

0.0

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Erste Bewertung verfassen

Unsere Kundinnen und Kunden meinen

0.0

0 Bewertungen filtern

Weitere Artikel finden Sie in

  • Uncertainty Modeling in Dose Response
  • Acknowledgments.

    Contributors.

    Introduction (Roger M. Cooke and Margaret MacDonell).

    1 Analysis of Dose-Response Uncertainty Using Benchmark Dose Modeling (Jeff Swartout).

    Comment: The Math/Stats Perspective on Chapter 1: Hard Problems Remain (Allan H. Marcus).

    Comment: EPI/TOX Perspective on Chapter 1: Re-formulating the Issues (Jouni T. Tuomisto).

    Comment: Regulatory/Risk Perspective on Chapter 1: A Good Baseline (Weihsueh Chiu).

    Comment: A Question Dangles (David Bussard).

    Comment: Statistical Test for Statistics-as-Usual Confidence Bands (Roger M. Cooke).

    Response to Comments (Jeff Swartout).

    2 Uncertainty Quantification for Dose-Response Models Using Probabilistic Inversion with Isotonic Regression: Bench Test Results (Roger M. Cooke).

    Comment: Math/Stats Perspective on Chapter 2: Agreement and Disagreement (Thomas A. Louis).

    Comment: EPI/TOX Perspective on Chapter 2: What Data Sets Per se Say (Lorenz Rhomberg).

    Comment: Regulatory/Risk Perspective on Chapter 2: Substantial Advances Nourish Hope for Clarity? (Rob Goble).

    Comment: A Weakness in the Approach? (Jouni T. Tuomisto).

    Response to Comments (Roger Cooke).

    3 Uncertainty Modeling in Dose Response Using Nonparametric Bayes: Bench Test Results (Lidia Burzala and Thomas A. Mazzuchi).

    Comment: Math/Stats Perspective on Chapter 3: Nonparametric Bayes (Roger M. Cooke).

    Comment: EPI/TOX View on Nonparametric Bayes: Dosing Precision (Chao W. Chen).

    Comment: Regulator/Risk Perspective on Chapter 3: Failure to Communicate (Dale Hattis).

    Response to Comments (Lidia Burzala).

    4 Quantifying Dose-Response Uncertainty Using Bayesian Model Averaging (Melissa Whitney and Louise Ryan).

    Comment: Math/Stats Perspective on Chapter 4: Bayesian Model Averaging (Michael Messner).

    Comment: EPI/TOX Perspective on Chapter 4: Use of Bayesian Model Averaging for Addressing Uncertainties in Cancer Dose-Response Modeling (Margaret Chu).

    Comment: Regulatorary/Risk Perspective on Chapter 4: Model Averages, Model Amalgams, and Model Choice (Adam M. Finkel).

    Response to Comments (Melissa Whitney and Louise Ryan).

    5 Combining Risks from Several Tumors Using Markov Chain Monte Carlo (Leonid Kopylev, John Fox, and Chao Chen).

    6 Uncertainty in Dose Response from the Perspective of Microbial Risk (P. F. M. Teunis).

    7 Conclusions (David Bussard, Peter Preuss, and Paul White).

    Author Index.

    Subject Index.